- Trials with a EudraCT protocol (573)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (95)
573 result(s) found for: Salbutamol.
Displaying page 1 of 29.
| EudraCT Number: 2016-002819-18 | Sponsor Protocol Number: WADA2016Sal | Start Date*: 2016-12-14 |
| Sponsor Name:Bispebjerg University Hospital | ||
| Full Title: Pharmacological effects of acute and accumulated salbutamol in relation to doping analysis | ||
| Medical condition: Pharmacological effects of acute and accumulated salbutamol in relation to doping analysis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-000725-18 | Sponsor Protocol Number: MAB110123 | Start Date*: 2008-04-03 |
| Sponsor Name:GlaxoSmithKline Reaseach & Development | ||
| Full Title: A randomised, double-blind, crossover study to investigate the bronchodilatation post-inhalation of GSK961081 alone and with the addition of cumulative doses of short acting bronchodilators (salbut... | ||
| Medical condition: Chronic Obstructive Pulmonary Disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-003600-12 | Sponsor Protocol Number: 12001 | Start Date*: 2012-10-29 |
| Sponsor Name:Sportmedisch expertisecentrum | ||
| Full Title: The effect of cold air on the airways of elite skaters and the protective role of the OMRON | ||
| Medical condition: Exericise induced bronchoconstriction | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001978-33 | Sponsor Protocol Number: 150400 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Brighton and Sussex University Hospitals NHS Trust | |||||||||||||
| Full Title: How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children? | |||||||||||||
| Medical condition: Recurrent wheeze in preschool children | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-002996-27 | Sponsor Protocol Number: 13CC34 | Start Date*: 2015-02-02 |
| Sponsor Name:Great Ormond Street Hospital For Children NHS Foundation Trust | ||
| Full Title: Optimising effectiveness and minimising toxicity of intravenous salbutamol in children with acute asthma | ||
| Medical condition: The mainstay of asthma treatment worldwide are β2-agonists and steroids. Current management of childhood acute asthma is based on British Thoracic Society guidelines, which recommend IVS as second ... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001317-28 | Sponsor Protocol Number: ABBA-2 | Start Date*: 2015-07-30 |
| Sponsor Name:UMC Utrecht | ||
| Full Title: A B2-agonist as a CFTR activator in CF - Part 2 | ||
| Medical condition: Cystic fibrosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005951-16 | Sponsor Protocol Number: UCI-01 | Start Date*: 2006-07-07 |
| Sponsor Name:Dr. Joan Ramon Masclans. Servicio de Medicina Intensiva. Hospital Universitario Vall d'Hebron | ||
| Full Title: Ensayo clínico piloto, aleatorizado, controlado con placebo, paralelo, doble ciego, para evaluar el efecto de salbutamol intravenoso sobre marcadores de inflamación en pacientes con síndrome de dis... | ||
| Medical condition: Síndrome de distrés respiratorio agudo | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-000473-12 | Sponsor Protocol Number: ULT01 | Start Date*: 2015-10-12 |
| Sponsor Name:UMCG | ||
| Full Title: The effectiveness of single dose Ultibro Breezhaler (indacaterol/glycopyrronium) by sd-DPI versus ipratropium/salbutamol by nebulizer in improving FEV1 and dyspnea during stable state of COPD | ||
| Medical condition: COPD, chronic obstructive pulmonary disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003377-15 | Sponsor Protocol Number: ERASMUS2007,Sofia2 | Start Date*: 2007-08-30 |
| Sponsor Name:Erasmus Hospital | ||
| Full Title: Chemoreflex sensitivity, exercise and beta agonists | ||
| Medical condition: Healthy participants | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-000276-40 | Sponsor Protocol Number: 04- SAL-02/BS536 | Start Date*: 2005-04-22 |
| Sponsor Name:GENERICS [UK] Ltd. | ||
| Full Title: A RANDOMISED, OPEN TWO WAY CROSS-OVER STUDY TO ASSESS THE BRONCHODILATING PROPERTIES OF A NEW SALBUTAMOL-HFA 134a FORMULATION GIVEN AS CUMULATIVE DOSES AND A REFERENCE SALBUTAMOL-HFA 134a FORMULAT... | ||
| Medical condition: Documented asthma for at least 6 months before screening Subjects with a FEV1 of between 50-85% of the predicted normal value for age, height and gender after withholding short acting Beta2-agonist... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-010381-30 | Sponsor Protocol Number: 2.4 | Start Date*: 2009-03-19 | |||||||||||
| Sponsor Name:Isala klinieken | |||||||||||||
| Full Title: Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia. | |||||||||||||
| Medical condition: Preterm infants developing bronchopulmonary dysplasia | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-002647-86 | Sponsor Protocol Number: BALTI-2, Version 2 | Start Date*: 2006-09-25 |
| Sponsor Name:Heart of England NHS Foundation Trust [...] | ||
| Full Title: BALTI-2: Beta Agonists in Lung Injury Trial | ||
| Medical condition: Acute respiratory distress syndrome (ARDS) | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-000057-37 | Sponsor Protocol Number: ABBA-2014 | Start Date*: 2014-04-30 |
| Sponsor Name:University Medical Centre Utrecht | ||
| Full Title: A B2-agonist as a CFTR activator in CF | ||
| Medical condition: Cystic Fibrosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-003551-22 | Sponsor Protocol Number: 55029 | Start Date*: 2016-12-28 | ||||||||||||||||
| Sponsor Name:Erasmus MC - Sophia Children's Hospital | ||||||||||||||||||
| Full Title: STATIC IV: Efficacy of a loading dose of intravenous salbutamol in patients admitted to a PICU for severe acute asthma | ||||||||||||||||||
| Medical condition: Severe acute (viral) wheeze and severe acute asthma | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2017-003118-15 | Sponsor Protocol Number: 97807 | Start Date*: 2017-10-31 | |||||||||||
| Sponsor Name:University Hospitals of Leicester NHS Trust | |||||||||||||
| Full Title: A double blind, placebo controlled, randomised dose escalation trial to investigate the safety and efficacy of topical salbutamol in the improvement of scar appearance when applied to approximated ... | |||||||||||||
| Medical condition: Improvement of (hypertrophic)scar appearance | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-000267-17 | Sponsor Protocol Number: VPI-103-01 | Start Date*: 2007-02-21 | |||||||||||
| Sponsor Name:Verus Pharmaceuticals Inc | |||||||||||||
| Full Title: A SINGLE CENTRE, GAMMA SCINTIGRAPHY STUDY IN ASTHMATIC PATIENTS TO COMPARE PULMONARY DEPOSITION AND PHARMACOKINETICS OF ALBUTEROL INHALATION SOLUTION (AIS) DELIVERED VIA eFLOW NEBULISER AND SALBUTA... | |||||||||||||
| Medical condition: The medical condition which is under investigation is Asthma. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-001912-53 | Sponsor Protocol Number: 137 | Start Date*: 2012-11-09 |
| Sponsor Name:Children's Hospital, Helsinki University Hospital | ||
| Full Title: Inhaled salbutamol in elective caesarean section | ||
| Medical condition: Neonatal pulmonary adaptation | ||
| Disease: | ||
| Population Age: Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: FI (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-003941-41 | Sponsor Protocol Number: ABR46374 | Start Date*: 2013-11-07 |
| Sponsor Name:Medisch Spectrum Twente | ||
| Full Title: Reversibility of pulmonary function after inhaling salbutamol in different doses in standard and forward leaning body posture in asthmatic children | ||
| Medical condition: Asthma | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-005160-27 | Sponsor Protocol Number: NAI009 | Start Date*: 2009-02-04 | |||||||||||
| Sponsor Name:The University of Dundee | |||||||||||||
| Full Title: A proof of concept study to evaluate rebound trough airway hyper-responsiveness after single and chronic dosing with levosalbutamol and racemic salbutamol in persistent asthmatics | |||||||||||||
| Medical condition: asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-022351-28 | Sponsor Protocol Number: 2010/38 | Start Date*: 2010-11-03 |
| Sponsor Name:Hôpital FOCH | ||
| Full Title: Essai prospectif randomisé, en double aveugle, comparant la Nalbuphine à l'association Hydroxyzine-Salbutamol dans la dystocie de démarrage. | ||
| Medical condition: Dystocie de Démarrage | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FR (Prematurely Ended) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
